The "Action Plan" proposes to strive to land a number of representative M&A cases in key industries by 2027, and cultivate about 10 internationally competitive listed companies in key industries such as integrated circuits, biomedicine and new materials."Because the industry is a typical' big money' industry, that is, high risk, long cycle and burning money, the nature of biomedicine also determines that it needs mergers and acquisitions in the current environment to become bigger and stronger."
Big move! Two billion M&A and restructuring funds in Shanghai have come to target the chip and pharmaceutical industries.Big move! Two billion M&A and restructuring funds in Shanghai have come to target the chip and pharmaceutical industries.For the biomedical industry, Bu Rixin told the reporter of science and technology innovation board Daily that the investment cycle of biomedicine is generally long, and it needs to go through multiple stages from research and development to listing.
A 10 billion yuan M&A fund for biomedical industry will also be set up.The "Action Plan" proposes to strive to land a number of representative M&A cases in key industries by 2027, and cultivate about 10 internationally competitive listed companies in key industries such as integrated circuits, biomedicine and new materials.The "10 billion yuan M&A fund for integrated circuit design industry" stated in the Action Plan is considered by the market as a supplement to the 100 billion yuan parent fund for the three leading industries.
Strategy guide
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14